7 results
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion … and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval … , or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring … , the safety, purity and potency. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted
S-1
APGE
Apogee Therapeutics, Inc.
22 Jun 23
IPO registration
4:19pm
, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting … . Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does
DRS/A
zddxbnl3
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
ya1v1fnd
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next